Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02999633
Title Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia (ISLAY)
Acronym ISLAY
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sanofi
Age Groups: child | senior | adult
Covered Countries USA | ITA | FRA

No variant requirements are available.